Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy
- 18 May 2012
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 25 (11) , 2202-2205
Abstract
Objective: To determine whether fetal hyperechogenic bowel is associated with a poor outcome with or without immunoglobulin therapy. Methods: Sixteen pregnant women whose 17 fetuses had hyperechogenic bowel were followed by a protocol of offering additional serologic testing, amniocentesis, hyperimmunoglobulin (HIG), serial ultrasounds, and evaluation of their children. Results: Of 17 fetuses with hyperechogenic bowel, 13 showed hyperechogenic bowel as a single or first ultrasound sign compared to four who showed it concomitantly or after other ultrasound abnormalities appeared (P = 0.02). Of the 17 fetuses with hyperechogenic bowel, nine were treated with HIG. Eight of the nine were normal at birth and during a follow-up of 3–8 years. One treated fetus is deaf at 4 years of age. A significantly different result (P < 0.0004) occurred among seven untreated fetuses who were each severely affected at 2–7 years of age, and the remaining one died soon after preterm birth. Among seven of nine fetuses (77.8%) of treated mothers the fetal hyperechogenic bowel resolved after HIG administration. There were no significant differences between treated and untreated fetuses for gestational age at maternal infection, gestational age at birth, and birth weight. Conclusion: Hyperechogenic bowel may be a marker of congenital cytomegalovirus (CMV) disease, which may be prevented by HIG.Keywords
This publication has 19 references indexed in Scilit:
- Immunoglobulin Therapy of Fetal Cytomegalovirus Infection Occurring in the First Half of Pregnancy--A Case-Control Study of the Outcome in ChildrenThe Journal of Infectious Diseases, 2011
- Cytomegalovirus infections during pregnancyCurrent Opinion in Obstetrics and Gynecology, 2011
- Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapyPrenatal Diagnosis, 2008
- New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infectionReviews in Medical Virology, 2007
- Placental Enlargement in Women with Primary Maternal Cytomegalovirus Infection Is Associated with Fetal and Neonatal DiseaseClinical Infectious Diseases, 2006
- Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcomeJournal of Clinical Virology, 2006
- TORCH test for fetal medicine indications: only CMV is necessary in the United KingdomPrenatal Diagnosis, 2005
- Passive Immunization during Pregnancy for Congenital Cytomegalovirus InfectionNew England Journal of Medicine, 2005
- Congenital cytomegalovirus infection: Outcome and diagnosisSeminars in Pediatric Infectious Diseases, 2005
- Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcomePrenatal Diagnosis, 2001